NCT05029622 - A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

August 21, 2022

Study Completion Date

February 13, 2023

Conditions

Central Precocious Puberty

Interventions

DRUG

Triptorelin Pamoate

Triptorelin 6-month formulation for IM on day 1 and Month 6.

Trial Locations (14)

Beijing Children's Hospital, Capital Medical University, Beijing

No.1 Hospital of Jilin University (Bethune first hospital of Jilin University), Changchun

Children's Hospital of Fudan University, Changhai

Wuxi children's Hospital, Wuxi

Children's Hospital of Soochow University, Suzhou

Shandong Provincial Hospital, Jinan

Linyi Maternal and Child Health Care Hospital, Linyi

Jiangxi Provincial Children's Hospital, Nanchang

Pingxiang Maternity and Child Care, Pingxiang

Hunan children's hospital, Changsha

Wuhan Children's Hospital Tongji Medical College Huazhong University of Science & Technology, Wuhan

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan

Zhengzhou Children's Hospital , Henan Children's Hospital, Zhengzhou

Chengdu Women's & Children's Central Hospital, Chengdu